From 2023 to 2028, India is projected to see a steady increase in the import of antisera and other blood fractions, measured in thousand kilograms. The forecasted growth indicates a continuous annual rise, showcasing healthy demand. Between 2024 and 2028, year-on-year growth averages around 3% to 4% as the imports move from 527.47 to 603.73 thousand kilograms. With no data provided for 2023, assuming a base year at a slightly lower volume could suggest a consistent upward trend beginning even before 2024.
Future trends to monitor include potential changes in global supply chains affected by geopolitical unrest and advancements in local manufacturing capabilities which may affect import volumes. Additionally, evolving healthcare policies and the demand for advanced medical treatments in India could influence future import needs.
